Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1980 1
1983 1
1987 1
1989 1
1990 1
1995 1
1997 2
1999 2
2000 2
2001 1
2002 1
2004 1
2006 1
2008 4
2010 1
2011 1
2012 1
2014 1
2015 1
2016 1
2017 3
2018 2
2020 1
2021 2
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Lung occult large cell carcinoma"
Page 1
Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma.
Kotecha RR, Flippot R, Nortman T, Guida A, Patil S, Escudier B, Motzer RJ, Albiges L, Voss MH. Kotecha RR, et al. J Natl Compr Canc Netw. 2021 Feb 12;19(4):432-438. doi: 10.6004/jnccn.2020.7634. Print 2021 Apr. J Natl Compr Canc Netw. 2021. PMID: 33578374 Free PMC article.
BACKGROUND: Metastatic renal cell carcinoma (mRCC) management guidelines recommend brain imaging if clinically indicated and the rate of occult central nervous system (CNS) metastasis is not well-defined. ...IMDC risk and number or size of lesions did not cor …
BACKGROUND: Metastatic renal cell carcinoma (mRCC) management guidelines recommend brain imaging if clinically indicated and t …
Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer.
Mitsui S, Tanaka Y, Jimbo N, Doi T, Tane S, Hokka D, Maniwa Y. Mitsui S, et al. Thorac Cancer. 2023 Jun;14(18):1774-1781. doi: 10.1111/1759-7714.14922. Epub 2023 May 9. Thorac Cancer. 2023. PMID: 37160414 Free PMC article.
BACKGROUND: Identifying the preoperative risk factors for lymph node upstaging could contribute to the development of individualized perioperative treatment for patients with non-small cell lung cancer (NSCLC). The current study aimed to evaluate the risk factors fo …
BACKGROUND: Identifying the preoperative risk factors for lymph node upstaging could contribute to the development of individualized periope …
Characteristics and prognosis of Japanese male and female lung cancer patients: The BioBank Japan Project.
Nakamura K, Ukawa S, Okada E, Hirata M, Nagai A, Yamagata Z, Ninomiya T, Muto K, Kiyohara Y, Matsuda K, Kamatani Y, Kubo M, Nakamura Y; BioBank Japan Cooperative Hospital Group; Tamakoshi A. Nakamura K, et al. J Epidemiol. 2017 Mar;27(3S):S49-S57. doi: 10.1016/j.je.2016.12.010. Epub 2017 Feb 13. J Epidemiol. 2017. PMID: 28202209 Free PMC article.
The proportions of histological types in males and females were 56.3% and 82.4% for adenocarcinoma, 26.9% and 8.2% for squamous cell carcinoma, 4.5% and 1.5% for large cell carcinoma, 7.7% and 4.1% for small cell carcinoma and 4.6% …
The proportions of histological types in males and females were 56.3% and 82.4% for adenocarcinoma, 26.9% and 8.2% for squamous cell …
Molecular staging of lung and esophageal cancer.
Lau CL, Moore MB, Brooks KR, D'Amico TA, Harpole DH Jr. Lau CL, et al. Surg Clin North Am. 2002 Jun;82(3):497-523. doi: 10.1016/s0039-6109(02)00024-5. Surg Clin North Am. 2002. PMID: 12371582 Review.
Significant research to investigate the biology of NSCLC and esophageal carcinoma is ongoing, and the roles of proto-oncogenes, tumor suppressor genes, angiogenic factors, extracellular matrix proteases, and adhesion molecules are being elucidated. ...Identification of …
Significant research to investigate the biology of NSCLC and esophageal carcinoma is ongoing, and the roles of proto-oncogenes, tumor …
Large cell neuroendocrine carcinoma of the lung: an aggressive disease potentially treatable with surgery.
Doddoli C, Barlesi F, Chetaille B, Garbe L, Thomas P, Giudicelli R, Fuentes P. Doddoli C, et al. Ann Thorac Surg. 2004 Apr;77(4):1168-72. doi: 10.1016/j.athoracsur.2003.09.049. Ann Thorac Surg. 2004. PMID: 15063228
BACKGROUND: Assessment of clinical and pathologic features of large cell neuroendocrine carcinoma to confirm its specificity in the setting of high grade neuroendocrine pulmonary tumors. ...The median age was 62 years. Four patients had a preoperative diagnos …
BACKGROUND: Assessment of clinical and pathologic features of large cell neuroendocrine carcinoma to confirm its specif …
Immune checkpoint inhibitor use and the incidence of hepatitis B virus reactivation or immune-related hepatitis in non-small cell lung cancer patients with chronic hepatitis B.
Hong J, Lee J, Park S, Jung HA, Sun JM, Lee SH, Ahn JS, Sinn DH, Ahn MJ. Hong J, et al. Cancer. 2024 May 1;130(9):1693-1701. doi: 10.1002/cncr.35175. Epub 2024 Jan 2. Cancer. 2024. PMID: 38165808
BACKGROUND: The safety of immune-checkpoint inhibitors (ICIs) has not been thoroughly investigated in non-small cell lung cancer (NSCLC) patients with chronic hepatitis B (CHB) or occult hepatitis B infection (OBI). ...The incidence of grade 3 other immune-re …
BACKGROUND: The safety of immune-checkpoint inhibitors (ICIs) has not been thoroughly investigated in non-small cell lung canc …
Clinical Misstagings and Risk Factors of Occult Nodal Disease in Non-Small Cell Lung Cancer.
Dyas AR, King RW, Ghanim AF, Cerfolio RJ. Dyas AR, et al. Ann Thorac Surg. 2018 Nov;106(5):1492-1498. doi: 10.1016/j.athoracsur.2018.05.045. Epub 2018 Jun 15. Ann Thorac Surg. 2018. PMID: 29908981
BACKGROUND: Our objective was to compare the clinical to the pathologic stage in patients with non-small cell lung cancer (NSCLC). METHODS: A prospective database from 1 surgeon was reviewed. ...Independent predictors of occult N1 disease included high …
BACKGROUND: Our objective was to compare the clinical to the pathologic stage in patients with non-small cell lung cancer (NSC …
Prevalence and Predictability of Occult Satellite Nodules in Clinical Stage Ia Non-small Cell Lung Cancer following Lobectomy.
Kneuertz PJ, Abdel-Rasoul M, D'Souza DM, Moffatt-Bruce SD, Merritt RE. Kneuertz PJ, et al. Clin Lung Cancer. 2023 May;24(3):e134-e140. doi: 10.1016/j.cllc.2022.12.009. Epub 2022 Dec 27. Clin Lung Cancer. 2023. PMID: 36682930 Free PMC article.

Female gender (3.1% vs. male 2.5%; P = .002) and non-squamous histology (adenocarcinoma 3.2% and large cell neuroendocrine 3.0% vs. squamous cell 1.9% tumors; P < .001) were associated with the presence of separate nodules. ...Other factors associated with

…
Female gender (3.1% vs. male 2.5%; P = .002) and non-squamous histology (adenocarcinoma 3.2% and large cell neuroendocrine 3.0 …
Complete mediastinal lymphadenectomy: the core component of the multidisciplinary therapy in resectable non-small cell lung cancer.
Zhong W, Yang X, Bai J, Yang J, Manegold C, Wu Y. Zhong W, et al. Eur J Cardiothorac Surg. 2008 Jul;34(1):187-95. doi: 10.1016/j.ejcts.2008.03.060. Epub 2008 May 23. Eur J Cardiothorac Surg. 2008. PMID: 18457958 Review.
Anatomic landmarks for 14 levels of intrapulmonary, hilar, and mediastinal lymph nodes stations are designated. Skip transfer and occult lymph node metastasis, confirmed by studies regarding the mode of spread of intrathoracic lymphatic metastasis, are two theoretical base …
Anatomic landmarks for 14 levels of intrapulmonary, hilar, and mediastinal lymph nodes stations are designated. Skip transfer and occult …
Radiographic manifestations of primary bronchogenic carcinoma.
Sider L. Sider L. Radiol Clin North Am. 1990 May;28(3):583-97. Radiol Clin North Am. 1990. PMID: 2158119 Review.
Metastases are less frequent in large cell carcinoma than in adenocarcinoma. Large cell carcinoma demonstrates better survival figures than does adenocarcinoma. Small cell carcinoma is the most aggressive of the four cell …
Metastases are less frequent in large cell carcinoma than in adenocarcinoma. Large cell carcinoma …
36 results